A patient with multiple sclerosis (MS) presents with right side weakness, diplopia, and inability to move the left eye medially when looking to the right, with nystagmus of the abducting right eye, what is the most likely structure involved?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medial Longitudinal Fasciculus (MLF) Lesion

The most likely structure involved is the medial longitudinal fasciculus (MLF), specifically on the left side (Answer D). This clinical presentation is classic for left internuclear ophthalmoplegia (INO), a hallmark manifestation of multiple sclerosis affecting the brainstem 1, 2.

Clinical Reasoning

The patient's presentation demonstrates the pathognomonic triad of INO:

  • Failure of left eye adduction (cannot move medially) when attempting rightward gaze 1, 2
  • Abduction nystagmus of the right eye during rightward gaze 2, 3
  • Diplopia specifically when looking to the right 4, 3

The MLF is the final common pathway for all conjugate horizontal eye movements, connecting the abducens nucleus (cranial nerve VI) on one side to the contralateral oculomotor nucleus (cranial nerve III) 4, 3. A left MLF lesion disrupts signals traveling from the right abducens nucleus to the left medial rectus subnucleus, preventing left eye adduction during rightward gaze 1, 2.

Why Other Options Are Incorrect

  • Frontal cortex (A): Would cause conjugate gaze deviation with both eyes moving together, not dissociated eye movements 1
  • Left thalamus (B): Does not produce this specific pattern of ocular motility dysfunction 1
  • Sixth cranial nerve (C): A right sixth nerve palsy would prevent right eye abduction, not left eye adduction, and would not produce abduction nystagmus 1, 3

Multiple Sclerosis Context

In young adults with MS, demyelinating plaques typically affect the pons where the MLF is located 1, 5. The American College of Radiology identifies MS as the leading cause of INO in patients under 50 years 1, 5. INO is one of the most frequent brainstem presentations of MS, with medial longitudinal fasciculus lesions causing characteristic failure of ipsilateral eye adduction and contralateral abduction nystagmus 2, 3.

Diagnostic Confirmation

High-resolution T2-weighted MRI of the brainstem is mandatory to confirm MLF lesions 1, 5. The American Academy of Ophthalmology recommends this imaging specifically to visualize demyelinating plaques in the pontine tegmentum 1, 6. In MS patients with INO, MRI typically reveals hyperintense lesions at the mid-pontine level where the MLF courses 3, 7.

Associated Right-Sided Weakness

The concurrent right-sided weakness indicates additional MS lesions beyond the MLF, likely involving corticospinal tracts elsewhere in the CNS 8. This multifocal involvement is characteristic of MS pathophysiology, with dissemination in space being a diagnostic criterion 8, 2.

Management Implications

Immediate neuroimaging with high-resolution brainstem MRI is indicated, and neurology consultation should be obtained to determine the underlying etiology and initiate disease-modifying therapy for MS 1. While vasculopathic INO in older adults typically resolves within 6 months, MS-related INO in younger patients requires long-term disease management 1, 2.

References

Guideline

Internuclear Ophthalmoplegia and Conjugate Gaze Palsy Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Disorders of vision in multiple sclerosis.

Clinical & experimental optometry, 2022

Guideline

Diagnostic Approach to Left Medial Longitudinal Fasciculus Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Does a left Medial Longitudinal Fasciculus (MLF) lesion cause internuclear ophthalmoplegia (INO) on the same side?
What is the appropriate management and treatment approach for a patient diagnosed with Medial Longitudinal Fasciculus (MLF) syndrome?
What is the most likely cause of a patient's jerking eye movement on lateral gaze, given a history of multiple sclerosis, myasthenia gravis (Muscle Weakness Disease), Graves' disease (Hyperthyroidism), cluster headaches, and neurofibromatosis?
What is the diagnostic approach for Medial Longitudinal Fasciculus (MLF) syndrome?
What is the recommended management for a patient with multiple sclerosis experiencing Amaurosis fugax?
What is the management for a patient with oral anticoagulant (OAC) induced bleeding, particularly those taking warfarin, dabigatran (Pradaxa), apixaban (Eliquis), or rivaroxaban (Xarelto), with potential impaired renal function and concomitant use of antiplatelet agents or nonsteroidal anti-inflammatory drugs (NSAIDs)?
What is the best oral antibiotic for an adult patient with cellulitis on the arm, without any underlying medical conditions or allergies?
What is Accutane (isotretinoin) used for in the treatment of acne, particularly in adolescents and young adults?
Is Latuda (lurasidone) recommended for patients with prolonged QTc interval?
What is the best approach to manage an elderly male patient with hypertension who is currently on losartan (angiotensin II receptor antagonist) 50mg, propranolol (beta blocker) ER 120mg, and tamsulosin (alpha blocker)?
What is the next step in managing a patient with a 3.2 cm hypodense structure in the left renal sinus, suspected to be either a renal artery aneurysm or parapelvic cyst, with multiple simple and hemorrhagic cysts in the left kidney?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.